Muhammad Akhyar Farrukh,Muhammad Rehan Gul,Muhammad Khaleeq-ur- Rahman
申请号：
US14516824
公开号：
US09555009B2
申请日:
2014.10.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention reports ciprofloxacin (CIP)-encapsulated polymeric nanoparticles and its antibacterial potential with a variety of gram positive and gram negative pathogenic bacteria. CIP-encapsulated nanoparticles of diethylaminoethyl cellulose (DEA-EC) are prepared by the multiple emulsion solvent evaporation method. CIP-encapsulated nanoparticles showed superior effectiveness to inhibit the growth of bacteria in-vitro.
